Rajnish Wellness share price
BSE: 541601Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹0.34.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹35 Cr3,472nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 1 Jun 2026
- 0.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −8.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 1 Jun 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 26,23,249
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 13 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹31 Crdown 69.58%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.12 CrQuarter to Mar 2026: −₹4.70 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 0.4%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
The years either side of a change of basis do not compare. From the year to Mar 2024, the company's revenue for that year, ₹77 Cr, differs from its quarters added, ₹76 Cr.
| ₹ crore | Sep 2024Filed 17 Oct | Dec 2024Filed 12 Feb | Mar 2025Filed 13 Jun | Jun 2025Filed 14 Aug | Sep 2025Filed 14 Nov | Dec 2025Filed 7 Feb | Mar 2026Filed 1 Jun | Jun 2026Filed 13 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17 | 9 | 6 | 5 | 12 | 23 | 102 | 31 |
| Net profit | 0 | 0 | 0 | 0 | 0 | −1 | −5 | 0 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 1.6% | 0.8% | −7.9% | 4.7% | 0.5% | −3.9% | −4.6% | 0.4% |
Business segments
In the year to Mar 2026 the company reports one business segment, Pharamceutical Business, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement. Not shown, EV/EBITDA: operating loss, last twelve months. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the year to Mar 2024: days before it are of the company before the change.PE ratio and valuation history
At or below today's level on 0.2% of 975 trading days over the last 5 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −56.5% | – | – | 0.0% |
| 3 years | −71.1% | – | – | 0.0% |
| 5 years | +19.1% | – | – | 0.0% |
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Rajnish Wellness in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Rajnish Wellness is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Vasundhara RasayansVRL | 43 | 7.3 | 1.0 | 6.8 | +3.5% | +49.9% | 15.4% | 13.3% | 1.48% |
 Kabra DrugsKABRADG | 38 | 5.0 | 1.3 | 3.3 | +1,743.5% | – | 28.0% | 28.4% | 0.00% |
 Medicamen OrganicsMEDIORG | 37 | – | – | – | −40.7% | −199.3% | −13.7% | – | 0.00% |
 Vista PharmaceuticalsVISTAPH | 36 | – | 1.0 | – | −60.4% | – | −28.7% | −32.5% | 0.00% |
 Roopa IndustriesROOPAIND | 34 | 269.3 | 2.0 | 7.7 | +3.7% | −93.7% | 0.7% | 15.4% | 0.00% |
 Jfl Life SciencesJFLLIFE | 34 | 5.0 | 0.7 | 4.6 | – | – | 15.9% | 15.9% | 0.00% |
 Sandu PharmaceuticalsSANDUPHQ | 33 | 18.5 | 0.8 | 8.8 | +4.2% | +10.3% | 4.1% | 5.3% | 2.94% |
 Medi CapsMEDICAPQ | 31 | – | 0.3 | – | −42.9% | – | −1.5% | −8.7% | 0.00% |
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
5 Sep · Business Responsibility and Sustainability Reporting (BRSR)
Rajnish Wellness share price by year
Each calendar year to 2025.Rajnish Wellness share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 0.49 | −65.7% | 1.49 | 0.45 |
| 2024 | 1.43 | −85.7% | 11.46 | 1.43 |
| 2023 | 9.97 | −32.6% | 20.20 | 9.90 |
| 2022 | 14.80 | +1,965.1% | 14.95 | 0.68 |
| 2021 | 0.72 | +275.0% | 2.43 | 0.15 |
| 2020 | 0.19 | −71.8% | 0.86 | 0.16 |
| 2019 | 0.68 | −64.8% | 2.56 | 0.68 |
| 2018 | 1.93 | – | 2.18 | 1.46 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 0.34 | 0.34 | 0.32 | 0.34 | 0.33 | 26,23,249 |
| 22 Oct 2026 | 0.36 | 0.36 | 0.33 | 0.34 | 0.34 | 55,64,657 |
| 21 Oct 2026 | 0.37 | 0.37 | 0.35 | 0.36 | 0.36 | 24,32,337 |
| 19 Oct 2026 | 0.36 | 0.37 | 0.36 | 0.36 | 0.36 | 15,02,990 |
| 16 Oct 2026 | 0.37 | 0.38 | 0.36 | 0.37 | 0.37 | 24,61,264 |
| 15 Oct 2026 | 0.36 | 0.40 | 0.35 | 0.37 | 0.37 | 81,91,007 |
| 14 Oct 2026 | 0.36 | 0.36 | 0.35 | 0.36 | 0.36 | 12,15,325 |
| 13 Oct 2026 | 0.36 | 0.36 | 0.35 | 0.35 | 0.36 | 11,49,402 |
| 12 Oct 2026 | 0.36 | 0.36 | 0.35 | 0.35 | 0.36 | 14,49,336 |
| 9 Oct 2026 | 0.35 | 0.36 | 0.34 | 0.36 | 0.35 | 31,27,099 |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 3 Jun 2025 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
| 10 Jan 2023 | Split | 0.5000 | Each share became 2. |
| 21 Jul 2022 | Bonus | 0.3333 | Holders received 2 bonus shares for every 1 held. |
| 21 Jul 2022 | Split | 0.2000 | Each share became 5. |
| 23 Dec 2021 | Bonus | 0.4444 | Holders received 5 bonus shares for every 4 held. |
| 13 Nov 2020 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 12 Feb 2020 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
Company details
- Legal name
- Rajnish Wellness Limited
- BSE code
- 541601
- ISIN
- INE685Z01033
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Jul 2018
- Face value
- ₹1
- CIN
- L52100MH2015PLC265526
- Corporate identity number, the registrar of companies' code for it